共 50 条
- [1] Letter by May et al Regarding Article, "Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation" [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (04): : E65 - E65
- [2] Response to Letter by May et al Regarding Article, "Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation" by Bassiouny et al. [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (04): : E66 - E66
- [3] Letter by Maesen et al Regarding Article, "Randomized Controlled Trial of Surgical Versus Catheter Ablation for Paroxysmal and Early Persistent Atrial Fibrillation" [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2019, 12 (03):
- [4] Response by Buist et al to Letter Regarding Article, "Randomized Controlled Trial of Surgical Versus Catheter Ablation for Paroxysmal and Early Persistent Atrial Fibrillation" [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2019, 12 (03):
- [8] Letter by Belley-Cote et al Regarding Article, "Randomized Controlled Trial of Surgical Versus Catheter Ablation for Paroxysmal and Early Persistent Atrial Fibrillation" [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2019, 12 (03):